{"id":"NCT01663623","sponsor":"Human Genome Sciences Inc., a GSK Company","briefTitle":"Belimumab in Remission of VASculitis","officialTitle":"A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03-20","primaryCompletion":"2017-02-06","completion":"2017-02-06","firstPosted":"2012-08-13","resultsPosted":"2018-04-17","lastUpdate":"2018-04-17"},"enrollment":106,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Vasculitis"],"interventions":[{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Belimumab 10 mg/kg","otherNames":["BENLYSTAâ„¢"]},{"type":"DRUG","name":"Azathioprine","otherNames":[]}],"arms":[{"label":"Placebo plus azathioprine","type":"PLACEBO_COMPARATOR"},{"label":"Belimumab 10 mg/kg plus azathioprine","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of belimumab, in combination with azathioprine, for the maintenance of remission following a standard induction regimen in patients with Wegener's granulomatosis or microscopic polyangiitis. The random assignment in this study is \"1 to 1\" which means that participants have an equal chance of receiving belimumab or placebo.","primaryOutcome":{"measure":"Time to First Relapse","timeFrame":"Approximately up to 4 years","effectByArm":[{"arm":"Placebo","deltaMin":null,"sd":null},{"arm":"Belimumab 10 mg/kg","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.884"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":89,"countries":["United States","Australia","Belgium","Canada","Czechia","France","Germany","Hungary","Ireland","Italy","Mexico","Norway","Peru","Poland","Romania","Russia","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["30666823"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":52},"commonTop":["Cough","Nasopharyngitis","Upper respiratory tract infection","Fatigue","Arthralgia"]}}